Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TheoPHyLNNe: Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
NCT05853601Phase 2Active, not recruiting
- Sponsor
- Medical College of Wisconsin
- Start
- Oct 2023
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of theophylline in acute kidney injury (AKI), sponsored by Medical College of Wisconsin. Started Oct 2023; status: active, not recruiting.
02
Drugs
theophylline
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05853601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05853601.